Provided by Tiger Trade Technology Pte. Ltd.

ZAI LAB

19.800
-0.880-4.26%
Volume:6.73M
Turnover:134.08M
Market Cap:22.53B
PE:-15.76
High:20.500
Open:20.500
Low:19.730
Close:20.680
52wk High:27.280
52wk Low:12.310
Shares:1.14B
HK Float Shares:1.14B
Volume Ratio:0.95
T/O Rate:0.59%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.256
ROE:-26.91%
ROA:-14.75%
PB:4.74
PE(LYR):-15.76
PS:6.39

Loading ...

Movement Alert|Zai Lab Falls 5.08% in Regular Trading, Partner Novocure TTFields Phase III Clinical Trial Failure Weighs on Stock

Market Focus
·
Jun 22

Zai Lab Shares Defy Market Trend with 7% Surge Following European Orphan Drug Designation for Zoci

Stock News
·
Jun 18

Movement Alert|Zai Lab Rises 5.75% in Regular Trading, Institutional Accumulation Filing Disclosed Amid Overnight US Rally

Market Focus
·
Jun 18

Zai Lab shareholders approve 10% share repurchase mandate at annual meeting

Reuters
·
Jun 18

Zai Lab says EMA grants orphan drug status to Zocilurtatug Pelitecan for pulmonary neuroendocrine carcinomas

Reuters
·
Jun 16

Zai Lab Receives Ema Orphan Drug Designation for Zocilurtatug Pelitecan (Zoci) in Pulmonary Neuroendocrine Carcinomas

THOMSON REUTERS
·
Jun 16

Movement Alert|Zai Lab Rises 5.57% in Regular Trading, Schizophrenia Drug Launch and Cervical Cancer Drug Approval Drive Dual Catalysts

Market Focus
·
Jun 10

Zai Lab Shares Surge on Dual Drug Approvals and Market Launches

Stock News
·
Jun 10

Zai Lab says China NMPA approves TIVDAK for recurrent or metastatic cervical cancer

Reuters
·
Jun 09

Zai Lab Receives China Nmpa Approval of Tivdak® (Tisotumab Vedotin for Injection) for the Treatment of Adult Patients With Recurrent or Metastatic Cervical Cancer

THOMSON REUTERS
·
Jun 09

Zai Lab files initial beneficial ownership statement for Operating Partner Wang Yizhe

Reuters
·
Jun 09

Movement Alert|Zai Lab Falls 5.05% in Regular Trading, Fundamentals Under Pressure Amid Broad Biotech Sector Weakness

Market Focus
·
Jun 05

HK Movers | Biotech Stocks Jump. Asymchem up Nearly 7%; SKB Bio up About 6%; Hengrui Pharma, Pharmaron, InnoGen up over 4%; Wuxi Apptec up 3%; Laekna, Joinn, Remegen up over 2%

Tiger Newspress
·
Jun 05

Zai Lab: No Change in Share Count for May 2026, USD 0.41 Million Raised from Option Exercises

Bulletin Express
·
Jun 04

Zai Lab Ltd Announces Grant of 5,000 Restricted Share Units

Stock News
·
Jun 03

Zai Lab grants 500 restricted share units under 2024 equity incentive plan

Reuters
·
Jun 03

Movement Alert|Zai Lab Rises 5.51% in Regular Trading, ASCO Annual Meeting Opening Catalyzes Biotech Sector Rebound

Market Focus
·
May 29

Movement Alert|Zai Lab Falls 5.03% in Regular Trading, President Dismissal Compounds Core Product Revenue Decline

Market Focus
·
May 28

Zai Lab Announces Leadership Change: President and COO to Step Down

Stock News
·
May 22

Zai Lab: President & COO Josh Smiley Steps Down; CEO Samantha Du Takes Over Operational Duties

Bulletin Express
·
May 22